Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 1.00 |
| ▸ | AHR | P35869 | 4/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 2/20 | 0.43 |
| ▸ | APP | P05067 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31208108 | 0.98 | CYP2A6 (0.96) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL10605 | 0.85 | CYP2A6 (0.73) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL31341461 | 0.83 | CYP2A6 (1.00) | CYP2A6AHRBACE1ALDH1A1KIF11 | |
| SCHEMBL97208 | 0.83 | CYP2A6 (1.00) | CYP2A6AHRBACE1ALDH1A1KIF11 | |
| SCHEMBL4931222 | 0.81 | CYP2A6 (0.67) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL31229934 | 0.79 | CYP2A6 (0.66) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL28312613 | 0.79 | CYP2A6 (0.66) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL8837852 | 0.79 | CYP2A6 (0.66) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL8051247 | 0.79 | CYP2A6 (0.66) | CYP2A6AHRCMA1TYRBACE1 | |
| SCHEMBL4950494 | 0.78 | CYP2A6 (0.60) | CYP2A6BACE1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 922 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119843490-A | Antibacterial deodorizing blended fabric, preparation method thereof and application thereof in underwear | 广东蓝天成实业有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-118652438-A | Zirconium-based metal organic framework and preparation method thereof | 深圳职业技术大学 | 2024-09-17 | — | — | CN | claimed |
| CN-117567436-A | Novel fluorescent dialdehyde compound, preparation method, chitosan Schiff base copper functional material and application thereof | 湖北工程学院 | 2024-02-20 | — | — | CN | claimed |
| WO-2023101943-A1 | METHODS AND COMPOSITIONS FOR MAINTAINING AND EXPANDING HEMATOPOIETIC STEM CELLS | TRAILHEAD BIOSYSTEMS INC. (US) | 2023-06-08 | — | — | WO | claimed |
| CN-112574093-B | Novel green method for preparing 3-diaryl methyl substituted indole compound | 湖南理工学院 | 2022-10-04 | — | — | CN | claimed |
| CN-110563716-B | Structure, preparation and application of 2-thiazole formaldehyde-6-indole Schiff base | 齐鲁工业大学 | 2022-09-30 | — | — | CN | claimed |
| CN-114302741-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2022-04-08 | — | — | CN | claimed |
| CN-108353906-B | Application of indole-3-formaldehyde and derivatives thereof in preventing and treating plant diseases caused by plant pathogenic fungi | 华南农业大学 | 2021-04-23 | — | — | CN | claimed |
| CN-112574093-A | Novel green method for preparing 3-diaryl methyl substituted indole compound | 湖南理工学院 | 2021-03-30 | — | — | CN | claimed |
| US-10787484-B2 | Compositions and methods for treating cardiovascular disease | GENENTECH, INC. (US) | 2020-09-29 | — | — | US | claimed |
| US-20070112000-A1 | Chemical compounds | ASTRAZENECA R&D ALDERLEY (GB) | 2007-05-17 | — | — | US | claimed |
| EP-1684757-A1 | SUBSTITUTED PIPERIDINES FOR THE TREATMENT OF METABOLIC SYNDROME | AstraZeneca AB (SE) | 2006-08-02 | — | — | EP | claimed |
| JP-2005530798-A | — | — | 2005-10-13 | — | — | JP | claimed |
| CN-1653050-A | Opioid and opioid-like compounds and uses thereof | JENKEN BIOSCIENCES INC (US) | 2005-08-10 | — | — | CN | claimed |
| WO-2005046685-A1 | SUBSTITUTED PIPERIDINES FOR THE TREATMENT OF METABOLIC SYNDROME | ASTRAZENECA AB (SE) | 2005-05-26 | — | — | WO | claimed |
| US-20050107415-A1 | Opioid and opioid-like compounds and uses thereof | JENKEN BIOSCIENCES, INC. | 2005-05-19 | — | — | US | claimed |
| EP-1506174-A2 | OPIOID AND OPIOID-LIKE COMPOUNDS AND USES THEREOF | Jenken Biosciences, Inc. (US) | 2005-02-16 | — | — | EP | claimed |
| WO-2003097608-A2 | OPIOID AND OPIOID-LIKE COMPOUNDS AND USES THEREOF | JENKEN BIOSCIENCES, INC. (US) | 2003-11-27 | — | — | WO | claimed |
| CN-1024626-C | Tetrahydrobenz [c,d] indole serotonin agonists | LILLY CO ELI (US) | 1994-05-25 | — | — | CN | claimed |
| CN-1046330-A | Tetrahydro benzo [c, d] indole serotonin stimulant | LILLY CO ELI (US) | 1990-10-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112000-A1 | Chemical compounds | HSD11B1, CYP11B1, HSD11B2 | CYP2A6 108/4885AHR 535/4885CMA1 815/4885 |
| US-10787484-B2 | Compositions and methods for treating cardiovascular disease | PCSK9, PCSK7, PCSK6 | CYP2A6 2648/4885AHR 2258/4885CMA1 283/4885 |
| US-20050107415-A1 | Opioid and opioid-like compounds and uses thereof | OPRL1, OPRK1, OPRM1 | CYP2A6 886/4885AHR 932/4885CMA1 3542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.